TORONTO, ON--(Marketwired - Mar 5, 2014) - Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce that RonnieColemanNutrition.com has placed its initial order for its TapouT pain relief line and supplements. This order will help fuel Axxess Pharma's continued acceleration of sales throughout the United States.
RonnieColemanNutrition.com features over 170 name-brand supplements and thousands of sports nutrition products for body builders, athletes and those who simply want to get in better shape and build muscle. The company was started by Gould, a marketing guru and Coleman, the eight-time winner of the Mr. Olympia body building competition and spokesperson for a number of the top supplements around the world.
"This is an exciting time for our company. We are honored to have our products listed and sold on RonnieColemanNutrition.com. Sales of our TapouT pain relief line and supplements continues to grow at a rapid rate throughout the United States," says Dr. Daniel Bagi, President of Axxess Pharma Inc.
Dr. Bagi further stated, "We anticipate record sales growth in 2014 based on our continued acceleration of month over month sales. We are now preparing to release additional high demand products in the coming months. These products have a history of generating strong residual revenues throughout North America."
"We're very excited to announce the initial PO for TapouT Muscle Recovery products from RonnieColemanNutrition.com. This is a great retail channel for TapouT to be reaching its targeted consumer, who's interested in any type of sport," says Mitch Gould, CEO of NPI. "With RonnieColemanNutrition.com, consumers will be available to purchase the entire line of TapouT Products."
About Nutritional Products International (NPI): Nutritional Products International (NPI) is a privately held company staffed with a complimentary team of marketing professionals that specializes in retail distribution of Nutraceuticals, Dietary Supplements, and Functional Beverages. NPI offers a unique proven approach for product manufacturers world wide seeking to launch or expand distribution of their products in the U.S. retail market. Gould, CEO of NPI, has worked with such icons as Steven Seagal, Hulk Hogan, Ronnie Coleman Mr. 8X Olympia, Bob Wall, Wayne Gretzky and Roberto Clemente, Jr. to name a few. For more information, visit www.nutricompany.com.
About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about TapouT Muscle Recovery products, please visit: www.tapoutmusclerecovery.com. For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.
About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks, estimated, expected, intended or projected. In each instance, forward-looking information should be and uncertainties.